These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 30598706)
1. Soluble HLA-I and HLA-II Molecules Are Potential Prognostic Markers of Progression of Systemic and Local Inflammation in Patients with COPD. Kubysheva N; Soodaeva S; Novikov V; Eliseeva T; Li T; Klimanov I; Kuzmina E; Baez-Medina H; Solovyev V; Ovsyannikov DY; Batyrshin I Dis Markers; 2018; 2018():3614341. PubMed ID: 30598706 [TBL] [Abstract][Full Text] [Related]
2. Associations between indicators of nitrosative stress and levels of soluble HLA-I, CD95 molecules in patients with COPD. Kubysheva N; Soodaeva S; Postnikova L; Novikov V; Maksimova A; Chuchalin A COPD; 2014 Dec; 11(6):639-44. PubMed ID: 24884928 [TBL] [Abstract][Full Text] [Related]
3. Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients. Kubysheva N; Postnikova L; Soodaeva S; Novikov V; Eliseeva T; Batyrshin I; Li T; Klimanov I; Chuchalin A Dis Markers; 2017; 2017():8216723. PubMed ID: 28848245 [TBL] [Abstract][Full Text] [Related]
4. The Differences in the Levels of Oxidative Status Marker and Soluble CD95 in Patients with Moderate to Severe COPD during an Exacerbation and a Stable Period. Soodaeva S; Kubysheva N; Klimanov I; Shutov A; Eliseeva T; Novikov V; Kontorshchikova K; Novikov D; Batyrshin I Oxid Med Cell Longev; 2021; 2021():2105406. PubMed ID: 34925689 [TBL] [Abstract][Full Text] [Related]
5. Soluble HLA in saliva of patients with autoimmune rheumatic diseases. Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679 [TBL] [Abstract][Full Text] [Related]
6. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients. Filaci G; Contini P; Brenci S; Gazzola P; Lanza L; Scudeletti M; Indiveri F; Mancardi GL; Puppo F Hum Immunol; 1997 Apr; 54(1):54-62. PubMed ID: 9154458 [TBL] [Abstract][Full Text] [Related]
7. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-beta1a treatment and their use as markers of disease activity. Minagar A; Adamashvilli I; Jaffe SL; Glabus MF; Gonzalez-Toledo E; Kelley RE Ann N Y Acad Sci; 2005 Jun; 1051():111-20. PubMed ID: 16126950 [TBL] [Abstract][Full Text] [Related]
9. Soluble HLA class I and class II concentrations in factor VIII and PCC preparations. Westhoff U; Grosse-Wilde H Vox Sang; 1995; 68(2):73-6. PubMed ID: 7762224 [TBL] [Abstract][Full Text] [Related]
10. Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status. Fireman Klein E; Adir Y; Krencel A; Peri R; Vasserman B; Fireman E; Kessel A Int J Chron Obstruct Pulmon Dis; 2019; 14():557-564. PubMed ID: 30880945 [TBL] [Abstract][Full Text] [Related]
11. Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations. Grosse-Wilde H; Blasczyk R; Westhoff U Tissue Antigens; 1992 Feb; 39(2):74-7. PubMed ID: 1574801 [TBL] [Abstract][Full Text] [Related]
12. Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. Filaci G; Contini P; Brenci S; Lanza L; Scudeletti M; Indiveri F; Puppo F Tissue Antigens; 1995 Aug; 46(2):117-23. PubMed ID: 7482504 [TBL] [Abstract][Full Text] [Related]
13. Soluble HLA class I and class II antigens in patients with multiple sclerosis. Ott M; Seidl C; Westhoff U; Stecker K; Seifried E; Fischer PA; Grosse-Wilde H Tissue Antigens; 1998 Mar; 51(3):301-4. PubMed ID: 9550332 [TBL] [Abstract][Full Text] [Related]
14. Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation. Morandi F; Venturi C; Rizzo R; Castellazzi M; Baldi E; Caniatti ML; Tola MR; Granieri E; Fainardi E; Uccelli A; Pistoia V J Neuroimmune Pharmacol; 2013 Sep; 8(4):944-55. PubMed ID: 23625177 [TBL] [Abstract][Full Text] [Related]
15. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia. Kippner L; Klint C; Sturfelt G; Bengtsson AA; Eriksson H; Truedsson L J Autoimmun; 2001 Jun; 16(4):471-8. PubMed ID: 11437496 [TBL] [Abstract][Full Text] [Related]
16. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692 [TBL] [Abstract][Full Text] [Related]
17. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627 [TBL] [Abstract][Full Text] [Related]
18. Correlation Between Tumor Necrosis Factor-α and Interleukin-1β in Exhaled Breath Condensate and Pulmonary Function. Lin X; Fan Y; Wang X; Chi M; Li X; Zhang X; Sun D Am J Med Sci; 2017 Oct; 354(4):388-394. PubMed ID: 29078843 [TBL] [Abstract][Full Text] [Related]
19. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction. Puppo F; Contini P; Ghio M; Indiveri F ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026 [TBL] [Abstract][Full Text] [Related]
20. Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers. Papaioannou AI; Loukides S; Minas M; Kontogianni K; Bakakos P; Gourgoulianis KI; Alchanatis M; Papiris S; Kostikas K Respir Res; 2011 May; 12(1):67. PubMed ID: 21600044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]